Australian State Inks Contract for Cepheid Platform, MRSA Test | GenomeWeb
NEW YORK (GenomeWeb News) – Cepheid said today that Australia’s State of Victoria will use the firm’s GeneXpert system and Xpert MRSA tests for screening patients at high risk for methicillin-resistant Staphylococcus aureus in up to 11 hospitals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.